Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation
暂无分享,去创建一个
Nathalie Arbour | Burkhard Becher | B. Becher | A. Prat | R. Cayrol | Monique Bernard | Igal Ifergan | Hania Kebir | Monique Bernard | Alexandre Prat | F. Giuliani | Hania Kebir | Katharina Kreymborg | I. Ifergan | A. Dodelet-Devillers | N. Arbour | Fabrizio Giuliani | Romain Cayrol | Aurore Dodelet-Devillers | Katharina Kreymborg
[1] Jack P Antel,et al. Th1 and Th2 lymphocyte migration across the human BBB is specifically regulated by interferon beta and copolymer-1. , 2005, Journal of autoimmunity.
[2] Qiang Tian,et al. Expression and regulation of IL-22 in the IL-17-producing CD4+ T lymphocytes , 2006, Cell Research.
[3] J. Antel,et al. Regulation of Th1 and Th2 Lymphocyte Migration by Human Adult Brain Endothelial Cells , 2001, Journal of neuropathology and experimental neurology.
[4] L. Fouser,et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides , 2006, The Journal of experimental medicine.
[5] A. Bouthillier,et al. Angiotensin II Controls Occludin Function and Is Required for Blood–Brain Barrier Maintenance: Relevance to Multiple Sclerosis , 2007, The Journal of Neuroscience.
[6] S. Szabo,et al. Loss of T-bet, But Not STAT1, Prevents the Development of Experimental Autoimmune Encephalomyelitis , 2004, The Journal of experimental medicine.
[7] Lawrence Steinman,et al. A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell–mediated tissue damage , 2007, Nature Medicine.
[8] S. Nakae,et al. IL-17 Plays an Important Role in the Development of Experimental Autoimmune Encephalomyelitis1 , 2006, The Journal of Immunology.
[9] C. Uyttenhove,et al. Development of an anti‐IL‐17A auto‐vaccine that prevents experimental auto‐immune encephalomyelitis , 2006, European journal of immunology.
[10] T. Mcclanahan,et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation , 2005, The Journal of experimental medicine.
[11] Roland Martin,et al. Immunology of multiple sclerosis. , 2005, Annual review of immunology.
[12] P. Valdez,et al. Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis , 2007, Nature.
[13] R. Kastelein,et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain , 2003, Nature.
[14] T. Owens,et al. Selective enrichment of Th1 CD45RBlow CD4+ T cells in autoimmune infiltrates in experimental allergic encephalomyelitis. , 1994, International immunology.